JP2009520766A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009520766A5 JP2009520766A5 JP2008546456A JP2008546456A JP2009520766A5 JP 2009520766 A5 JP2009520766 A5 JP 2009520766A5 JP 2008546456 A JP2008546456 A JP 2008546456A JP 2008546456 A JP2008546456 A JP 2008546456A JP 2009520766 A5 JP2009520766 A5 JP 2009520766A5
- Authority
- JP
- Japan
- Prior art keywords
- acetone
- solvent
- ethanol
- iii
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005061624.0 | 2005-12-21 | ||
| DE102005061624A DE102005061624A1 (de) | 2005-12-21 | 2005-12-21 | Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen |
| PCT/EP2006/070034 WO2007071743A1 (en) | 2005-12-21 | 2006-12-20 | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009520766A JP2009520766A (ja) | 2009-05-28 |
| JP2009520766A5 true JP2009520766A5 (https=) | 2013-03-21 |
| JP5317702B2 JP5317702B2 (ja) | 2013-10-16 |
Family
ID=37950582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546456A Active JP5317702B2 (ja) | 2005-12-21 | 2006-12-20 | ４−（ベンゾイミダゾリルメチルアミノ）−ベンゾアミドの塩の改良された製造方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7880016B2 (https=) |
| EP (1) | EP1968949B1 (https=) |
| JP (1) | JP5317702B2 (https=) |
| KR (1) | KR101411961B1 (https=) |
| CN (1) | CN101346355B (https=) |
| AR (1) | AR058571A1 (https=) |
| AT (1) | ATE485279T1 (https=) |
| AU (1) | AU2006326980B2 (https=) |
| BR (1) | BRPI0620150A2 (https=) |
| CA (1) | CA2632310C (https=) |
| CY (1) | CY1111113T1 (https=) |
| DE (2) | DE102005061624A1 (https=) |
| DK (1) | DK1968949T3 (https=) |
| ES (1) | ES2355045T3 (https=) |
| IL (1) | IL192242A (https=) |
| NZ (1) | NZ569636A (https=) |
| PL (1) | PL1968949T3 (https=) |
| PT (1) | PT1968949E (https=) |
| RU (1) | RU2425827C2 (https=) |
| SI (1) | SI1968949T1 (https=) |
| TW (1) | TWI411608B (https=) |
| WO (1) | WO2007071743A1 (https=) |
| ZA (1) | ZA200804198B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030181488A1 (en) | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
| DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
| DE102005061623A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
| DE102006054005A1 (de) * | 2006-11-16 | 2008-05-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
| US7767589B2 (en) * | 2007-02-07 | 2010-08-03 | Raytheon Company | Passivation layer for a circuit device and method of manufacture |
| US8173906B2 (en) * | 2007-02-07 | 2012-05-08 | Raytheon Company | Environmental protection coating system and method |
| US20110129538A1 (en) * | 2008-03-28 | 2011-06-02 | Boehringer Ingelheim International Gmbh | Process for preparing orally administered dabigatran formulations |
| AR072143A1 (es) * | 2008-06-16 | 2010-08-11 | Boehringer Ingelheim Int | Procedimiento para la preparacion de un producto intermedio para la sintesis de etexilato de dabigatran |
| JP5642670B2 (ja) * | 2008-06-16 | 2014-12-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ダビガトランの合成の中間体の製造方法 |
| JP2011527318A (ja) | 2008-07-14 | 2011-10-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ダビガトランを含有する医薬組成物の製造方法 |
| AU2009315729A1 (en) | 2008-11-11 | 2010-05-20 | Boehringer Ingelheim International Gmbh | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
| US8399678B2 (en) | 2009-11-18 | 2013-03-19 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dabigatran etexilate |
| JP2013521318A (ja) * | 2010-03-08 | 2013-06-10 | ラティオファルム ゲー・エム・ベー・ハー | ダビガトランエテキシラートを含有する医薬組成物 |
| US9006448B2 (en) * | 2010-12-06 | 2015-04-14 | Msn Laboratories Private Limited | Process for the preparation of benzimidazole derivatives and its salts |
| EP2522662A1 (en) | 2011-05-11 | 2012-11-14 | Medichem, S.A. | Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers |
| WO2013150545A2 (en) * | 2012-04-02 | 2013-10-10 | Msn Laboratories Limited | Process for the preparation of benzimidazole derivatives and salts thereof |
| EP2890692A1 (en) | 2012-08-31 | 2015-07-08 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate |
| US9399616B2 (en) | 2012-10-22 | 2016-07-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of 4-aminobenzoamidine dihydrochloride |
| US10077251B2 (en) | 2012-10-29 | 2018-09-18 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the synthesis of Dabigatran Etexilate and its intermediates |
| WO2014068587A2 (en) * | 2012-10-29 | 2014-05-08 | Biophore India Pharmaceuticals Pvt. Ltd. | An improved process for the synthesis of dabigatran and its intermediates |
| CN103275065A (zh) * | 2013-05-30 | 2013-09-04 | 上海同昌生物医药科技有限公司 | 一种新的生产达比加群酯的方法 |
| EP2835370A1 (en) | 2013-08-08 | 2015-02-11 | Medichem, S.A. | New crystals of dabigatran etexilate mesylate |
| US10112901B2 (en) | 2014-07-03 | 2018-10-30 | Shanghai Institute Of Pharmaceutical Industry | Method for preparing dabigatran etexilate intermediate, and intermediate compound |
| CN105461686A (zh) * | 2014-08-25 | 2016-04-06 | 江苏豪森药业股份有限公司 | 制备高纯度甲磺酸达比加群酯晶型的方法 |
| CN104987323B (zh) * | 2015-07-10 | 2017-08-22 | 浙江美诺华药物化学有限公司 | 一种达比加群酯的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087380A (en) * | 1949-11-24 | 2000-07-11 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions |
| PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
| DE19743435A1 (de) * | 1997-10-01 | 1999-04-08 | Merck Patent Gmbh | Benzamidinderivate |
| TWI248435B (en) * | 1998-07-04 | 2006-02-01 | Boehringer Ingelheim Pharma | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
| US6248770B1 (en) * | 1998-07-09 | 2001-06-19 | Boehringer Ingelheim Pharma Kg | Benzimidazoles having antithrombotic activity |
| DE19962329A1 (de) | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel |
| US6451832B2 (en) * | 1999-12-23 | 2002-09-17 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
| CA2476054C (en) * | 2002-03-07 | 2011-11-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof |
| NL1026498C2 (nl) * | 2004-06-24 | 2005-12-28 | Free Lift B V | Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid. |
| EP1609784A1 (de) * | 2004-06-25 | 2005-12-28 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen |
| DE102005061623A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
-
2005
- 2005-12-21 DE DE102005061624A patent/DE102005061624A1/de not_active Withdrawn
-
2006
- 2006-12-20 TW TW095148016A patent/TWI411608B/zh not_active IP Right Cessation
- 2006-12-20 AT AT06830756T patent/ATE485279T1/de active
- 2006-12-20 EP EP06830756A patent/EP1968949B1/en active Active
- 2006-12-20 SI SI200630879T patent/SI1968949T1/sl unknown
- 2006-12-20 JP JP2008546456A patent/JP5317702B2/ja active Active
- 2006-12-20 KR KR1020087017836A patent/KR101411961B1/ko active Active
- 2006-12-20 DE DE602006017743T patent/DE602006017743D1/de active Active
- 2006-12-20 CA CA2632310A patent/CA2632310C/en active Active
- 2006-12-20 ES ES06830756T patent/ES2355045T3/es active Active
- 2006-12-20 DK DK06830756.0T patent/DK1968949T3/da active
- 2006-12-20 WO PCT/EP2006/070034 patent/WO2007071743A1/en not_active Ceased
- 2006-12-20 AR ARP060105633A patent/AR058571A1/es not_active Application Discontinuation
- 2006-12-20 PT PT06830756T patent/PT1968949E/pt unknown
- 2006-12-20 AU AU2006326980A patent/AU2006326980B2/en active Active
- 2006-12-20 BR BRPI0620150-4A patent/BRPI0620150A2/pt not_active Application Discontinuation
- 2006-12-20 CN CN2006800488945A patent/CN101346355B/zh active Active
- 2006-12-20 NZ NZ569636A patent/NZ569636A/en unknown
- 2006-12-20 PL PL06830756T patent/PL1968949T3/pl unknown
- 2006-12-20 RU RU2008129637/04A patent/RU2425827C2/ru active
- 2006-12-21 US US11/614,299 patent/US7880016B2/en active Active
-
2008
- 2008-05-15 ZA ZA200804198A patent/ZA200804198B/xx unknown
- 2008-06-17 IL IL192242A patent/IL192242A/en active IP Right Grant
-
2011
- 2011-01-14 CY CY20111100047T patent/CY1111113T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009520766A5 (https=) | ||
| US9416097B2 (en) | Crystalline minocycline base and processes for its preparation | |
| EP3733717A2 (en) | An improved process for the preparation of sugammadex | |
| CN105418642B (zh) | 一种含噻唑吡啶酮结构的甲基丙烯酸酯荧光单体及其制备方法 | |
| CN102617410B (zh) | 一种3,4,5,6-四卤代酚磺酞的纯化方法 | |
| CN105198841B (zh) | 一种药物中间体多取代呋喃类化合物的合成方法 | |
| JP5793134B2 (ja) | ペリレンテトラカルボン酸ジイミド化合物を含有してなる有機半導体材料、及び有機半導体素子 | |
| CN102924474A (zh) | 一种氯吡格雷硫酸氢盐晶型ⅰ的制备方法 | |
| ITMI20131307A1 (it) | Processo per la preparazione di refaximina k | |
| CN100584845C (zh) | (+)-(s-)-氯吡格雷硫酸氢盐高熔点晶型i的制备方法 | |
| CN104774150B (zh) | 一种双醋瑞因晶体及其制备方法 | |
| CN109535140A (zh) | 一种基于肟酯与吲哚构建双吲哚取代二氢吡咯酮类衍生物的方法 | |
| CN104961676B (zh) | 烟酰胺类衍生物的甲磺酸盐a晶型及其制备方法和应用 | |
| WO2017219768A1 (zh) | 氯虫苯甲酰胺的多晶型及其制备方法 | |
| CN106397317A (zh) | 1,2,3,4‑四氢喹啉化合物及其合成方法与应用 | |
| CN107011322A (zh) | 一种高纯度脱氢苯基阿夕斯丁类化合物的制备纯化方法 | |
| CN104844669A (zh) | 一种黄芩苷a晶型、其制备方法及其应用 | |
| CN103880693B (zh) | 一种γ-氨基丁酸酯衍生物的合成方法 | |
| JP6474276B2 (ja) | ピセノジチオフェン化合物、有機半導体材料、有機半導体層、有機半導体素子 | |
| CN104860864B (zh) | 2‑羰基‑5‑炔基吡咯化合物的合成方法 | |
| CN104030977B (zh) | 一种达比加群酯中间体的制备方法 | |
| CN104592109A (zh) | 一种8-溴喹啉衍生物的制备方法 | |
| CN103724323B (zh) | 泊马度胺的制备方法 | |
| EP2542550A1 (en) | Process for the direct preparation of malic acid salt of sunitinib | |
| CN101747274A (zh) | 布南色林晶型a的制备方法 |